Literature DB >> 23147723

Clonal composition and community clustering of drug-susceptible and -resistant Escherichia coli isolates from bloodstream infections.

Sheila Adams-Sapper1, Binh An Diep, Francoise Perdreau-Remington, Lee W Riley.   

Abstract

Multidrug-resistant Escherichia coli strains belonging to a single lineage frequently account for a large proportion of extraintestinal E. coli infections in many parts of the world. However, limited information exists on the community prevalence and clonal composition of drug-susceptible E. coli strains. Between July 2007 and September 2010, we analyzed all consecutively collected Gram-negative bacterial isolates from patients with bloodstream infection (BSI) admitted to a public hospital in San Francisco for drug susceptibility and associated drug resistance genes. The E. coli isolates were genotyped for fimH single nucleotide polymorphisms (SNPs) and multilocus sequence types (MLSTs). Among 539 isolates, E. coli accounted for 249 (46%); 74 (30%) of them were susceptible to all tested drugs, and 129 (52%) were multidrug resistant (MDR). Only five MLST genotypes accounted for two-thirds of the E. coli isolates; the most common were ST131 (23%) and ST95 (18%). Forty-seven (92%) of 51 ST131 isolates, as opposed to only 8 (20%) of 40 ST95 isolates, were MDR (P < 0.0001). The Simpson's diversity index for drug-susceptible ST genotypes was 87%, while the index for MDR ST genotypes was 81%. ST95 strains were comprised of four fimH types, and one of these (f-6) accounted for 67% of the 21 susceptible isolates (P < 0.003). A large proportion (>70%) of both MDR and susceptible E. coli BSI isolates represented community-onset infections. These observations show that factors other than the selective pressures of antimicrobial agents used in hospitals contribute to community-onset extraintestinal infections caused by clonal groups of E. coli regardless of their drug resistance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23147723      PMCID: PMC3535975          DOI: 10.1128/AAC.01025-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France.

Authors:  Thierry Naas; Gaelle Cuzon; Olivier Gaillot; René Courcol; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

2.  Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.

Authors:  Umaer Naseer; Bjørg Haldorsen; Ståle Tofteland; Kristin Hegstad; Flemming Scheutz; Gunnar Skov Simonsen; Arnfinn Sundsfjord
Journal:  APMIS       Date:  2009-07       Impact factor: 3.205

3.  Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates.

Authors:  Johann D D Pitout; Deirdre L Church; Daniel B Gregson; Barbara L Chow; Melissa McCracken; Michael R Mulvey; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2007-02-05       Impact factor: 5.191

4.  Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.

Authors:  Johann D D Pitout; Daniel B Gregson; Lorraine Campbell; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2009-04-20       Impact factor: 5.191

5.  Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs).

Authors:  Sara Y Tartof; Owen D Solberg; Lee W Riley
Journal:  J Med Microbiol       Date:  2007-10       Impact factor: 2.472

6.  Global spread of mobile antimicrobial drug resistance determinants in human and animal Escherichia coli and Salmonella strains causing community-acquired infections.

Authors:  Remi M Ajiboye; Owen D Solberg; Bryan M Lee; Eva Raphael; Chitrita Debroy; Lee W Riley
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

7.  Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004.

Authors:  James R Johnson; Megan Menard; Brian Johnston; Michael A Kuskowski; Kim Nichol; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

8.  Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains.

Authors:  Olivier Clermont; Hiran Dhanji; Mathew Upton; Tarek Gibreel; Andrew Fox; David Boyd; Michael R Mulvey; Patrice Nordmann; Etienne Ruppé; Jean Louis Sarthou; Thierry Frank; Sophie Vimont; Guillaume Arlet; Catherine Branger; Neil Woodford; Erick Denamur
Journal:  J Antimicrob Chemother       Date:  2009-05-27       Impact factor: 5.790

9.  Molecular Analysis of Escherichia coli from retail meats (2002-2004) from the United States National Antimicrobial Resistance Monitoring System.

Authors:  James R Johnson; James S McCabe; David G White; Brian Johnston; Michael A Kuskowski; Patrick McDermott
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

10.  Retail meat consumption and the acquisition of antimicrobial resistant Escherichia coli causing urinary tract infections: a case-control study.

Authors:  Amee R Manges; Sherry P Smith; Briana J Lau; Christaline J Nuval; Joseph N S Eisenberg; Peter S Dietrich; Lee W Riley
Journal:  Foodborne Pathog Dis       Date:  2007       Impact factor: 3.171

View more
  50 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Distribution of genotypes between CTX-M-producing and non-extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates.

Authors:  Yong Gyu Park; Irene Jo; Yeon-Joon Park
Journal:  Antimicrob Agents Chemother       Date:  2015-07       Impact factor: 5.191

3.  Persistent Pandemic Lineages of Uropathogenic Escherichia coli in a College Community from 1999 to 2017.

Authors:  Reina Yamaji; Julia Rubin; Erika Thys; Cindy R Friedman; Lee W Riley
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

4.  Whole-Genome Analysis of Antimicrobial-Resistant and Extraintestinal Pathogenic Escherichia coli in River Water.

Authors:  Ryota Gomi; Tomonari Matsuda; Yasufumi Matsumura; Masaki Yamamoto; Michio Tanaka; Satoshi Ichiyama; Minoru Yoneda
Journal:  Appl Environ Microbiol       Date:  2017-02-15       Impact factor: 4.792

5.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

Review 6.  A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 7.  The population genetics of pathogenic Escherichia coli.

Authors:  Erick Denamur; Olivier Clermont; Stéphane Bonacorsi; David Gordon
Journal:  Nat Rev Microbiol       Date:  2020-08-21       Impact factor: 60.633

8.  The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Sujay Chattopadhyay; Veronika Tchesnokova; Evgeni V Sokurenko; James R Johnson
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

9.  An Enzyme-Mediated Amplification Strategy Enables Detection of β-Lactamase Activity Directly in Unprocessed Clinical Samples for Phenotypic Detection of β-Lactam Resistance.

Authors:  Tara R deBoer; Nicole J Tarlton; Reina Yamaji; Sheila Adams-Sapper; Tiffany Z Wu; Santanu Maity; Giri K Vesgesna; Corinne M Sadlowski; Peter DePaola; Lee W Riley; Niren Murthy
Journal:  Chembiochem       Date:  2018-09-26       Impact factor: 3.164

10.  Escherichia coli ST131: variations on a theme of clonal expansion.

Authors:  Ritu Banerjee; James R Johnson
Journal:  Enferm Infecc Microbiol Clin       Date:  2013-03-06       Impact factor: 1.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.